Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 05, 2019

SELL
$123.4 - $148.55 $10,242 - $12,329
-83 Closed
0 $0
Q4 2018

Jan 31, 2019

SELL
$105.09 - $137.23 $24,380 - $31,837
-232 Reduced 73.65%
83 $9,000
Q3 2018

Nov 07, 2018

BUY
$112.11 - $134.54 $35,314 - $42,380
315 New
315 $42,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.66B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Interstate Bank Portfolio

Follow First Interstate Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Interstate Bank with notifications on news.